Skip to content

Vor Biopharma VOR Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$219.59M-$812.68M+48.4%-$1.57B-4,744%-$32.49M-5.8%
$28K+21.7%$23K+1,050%$2K-99.9%$2.1M+155%$825K-4.6%
$8.87M+24.8%$7.11M-11.5%$8.03M+335%$1.84M-4.6%$1.93M+13.1%
-$38.25M-67.7%-$22.8M+57.5%-$53.66M-52.5%-$35.18M-13.3%-$31.07M-29.1%
$48K-84.7%$314K+28.7%$244K+60.5%$152K-34.2%$231K+221%
-$263.24M-438%-$48.97M-19,971%-$244K-138%$646K+381%-$230K
$74.87M-75.7%$307.8M+1,328%$21.55M-87.7%$175.07M+28,989%-$606K-101%
-$226.61M-196%$236.02M$140.53M+540%-$31.9M-209%
-$38.29M-65.7%-$23.12M+57.1%-$53.91M-52.6%-$35.34M-12.9%-$31.3M-29.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Vor Biopharma generate?
Vor Biopharma (VOR) generated -$149.9M in operating cash flow over the trailing twelve months.
What is Vor Biopharma's free cash flow?
After $758.0K of capital expenditures, Vor Biopharma's free cash flow was -$150.7M over the trailing twelve months, down 49.7% year over year.
Where does Vor Biopharma's cash flow data come from?
Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.